Homocysteine-Lowering Treatment With Folic Acid, Cobalamin, and Pyridoxine Does Not Reduce Blood Markers of Inflammation, Endothelial Dysfunction, or Hypercoagulability in Patients With Previous Transient Ischemic Attack or Stroke

Petcharat Dusitanond, John W. Eikelboom, Graeme J. Hankey, +9

Stroke

A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction

Dylan M. Zylla, Justin Eklund, Grace Gilmore, +10

Supportive Care in Cancer

Dose RequirementsMedical CannabisCannabis UseSubstance UseHealth Sciences +9

Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial

John W. Eikelboom, Graeme J. Hankey, Jim Thom, +6

Journal of Thrombosis and Haemostasis

ThrombosisCardiovascular DiseaseBlood PlateletPharmacologyHematology +5

Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa

Emmanuel J. Favaloro, Grace Gilmore, Sandya Arunachalam, +2

Thrombosis Research

ThrombosisLupusMedicineHematologyAndexanet Alfa +7

Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties

Q. Hughes, Bao T. Le, Grace Gilmore, +2

Molecules

Improved PropertiesThrombosisMedicinal ChemistryBiochemistryNatural Sciences +13

Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy

Dylan M. Zylla, Grace Gilmore, Justin Eklund, +2

Journal of Diabetes and its Complications

Diabetes ManagementMedicineCancer ManagementDiabetesDiabetes Mellitus +4

The tissue factor pathway in ischemic stroke

Jim Thom, Graeme J. Hankey, Ross Baker, +3

Blood Coagulation & Fibrinolysis

ImmunologyCerebrovascular DiseaseAcute PhaseCerebral Vascular RegulationThrombosis +16

Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects

Emmanuel J. Favaloro, Grace Gilmore, Roslyn Bonar, +4

Haemophilia

Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interference

Emmanuel J. Favaloro, Grace Gilmore, Roslyn Bonar, +4

Clinical Chemistry and Laboratory Medicine (CCLM)

Antistreptokinase antibodies: implications for thrombolysis in a region with endemic streptococcal infection: Table 1

Nikki Blackwell, Andrew Hollins, Grace Gilmore, +1

Journal of Clinical Pathology